IL6 and neoplasm: Functionally, myCAFs promote tumor invasion by enhancing ECM deposition and remodeling matrix mechanics, whereas iCAFs modulate the immune microenvironment by secreting inflammatory factors, such as IL6 and CXCL12, to support tumor growth [56,57].